Instructions for General Session Oral presentations at the 2024 San Antonio Breast Cancer Symposium®, December 10-13, 2024, at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
You will receive a separate email with information on the submission portal where you will complete all necessary tasks for your presentation.
Please use the information below in preparing your General Session Oral presentation.
| Presentation Length |
All oral presentations are expected to be given in-person in San Antonio.
The length of your talk is 10 minutes, with 5 minutes for Q&A. |
| Format |
|
Presentation slides must be in PowerPoint; other formats will not be supported. Your slides must be displayed in 16.9 format. Each presentation must include a list of financial disclosures for the presenting author on the second slide for CME purposes.
1. Title/Acknowledgment and financial disclosures (please note, financial disclosures are required)
2. Hypothesis/Objectives and Methods
3. Results
|
4. Conclusions/Implications/Next steps |
| Header & Footer |
Each presentation slide must include the following text:
Header: San Antonio Breast Cancer Symposium, December 10-13, 2024
Footer: This presentation is the intellectual property of the author/presenter. Contact them at insert your email address here for permission to reprint and/or distribute.
|
| Slide Template |
2024 SABCS® Presentation Slide Template |
| Presentation Review |
Final presentation slides must be in electronic format and uploaded to the submission portal for review for CME accredidation no later than Tuesday, November 12, 2024. Instructions regarding uploading the presentation will be sent to the presenting author separately. |
| Preview your Presentation |
You must meet with SABCS® AV technicians the day prior to your presentation in the Speaker Ready Room, Concourse Level, Room 225CD. Reviewing with the technician will help ensure a flawless presentation. The last slides we receive will be uploaded and used for your presentation. |
| Cancellation policy |
If for any reason your presentation must be cancelled, notify the Symposium office in writing as early as possible by email to sabcs@uthscsa.edu. Be sure to mention your assigned program number which appears at the top of your acceptance notification. |
Your slides will be made available online for viewing and downloadable in PDF format after your presentation. Slides will also be included on the virtual site and SABCS® website after the symposium concludes. You agree to give your permission to reproduce and post your slides and presentation unless you notify the SABCS® office at sabcs@uthscsa.edu.
It is expected that all presenters will give an unbiased presentation without using product promotion and will not discuss content or make clinical recommendations in their "conflict-of-interest" area. A content expert will be asked to review presentation content and rate for the absence of commercialism, product promotion, bias, or unresolved conflict of interest. This review will take place both prior to and during the presentation.
SABCS®, as copyright owner, has sole authority to grant permission to reproduce the abstract. Authors of SABCS® abstracts are permitted to use their abstracts in the following ways without requesting permission from SABCS®. All such uses must include appropriate attribution to the Cancer Research supplement issue in which the abstracts are published. Authors may:
- Reproduce the abstract, including tables, in books, reviews, or subsequent research articles they write.
- Use the abstract in presentations.
- Post a link to the online version of the abstract on their institutional website, if this is required by their institution.
- Submit a copy of their article to their university in support of a doctoral thesis.
SABCS Rules for repeat presentations
Senior investigators:
1) Individuals should not have more than one General Session Oral Presentation.
2) Individuals should not have more than two presentations at Rapid Fire Mini-Oral presentations, Poster Spotlights, or Late-Breaking Abstracts.
Junior investigators:
1) Individuals should not have more than two General Session Oral Presentations.
2) Individuals should not have more than three presentations at Rapid Fire Mini-Oral presentations, Poster Spotlights, or Late-Breaking Abstracts.